Tezacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator used in combination therapy to treat cystic fibrosis. This category offers a comprehensive range of Tezacaftor reference… Read more


![Chemical structure of (R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1152311-90-4-R-1-22-Difluorobenzod13dioxol-5-yl-N-1-22-dimethyl-13-dioxolan-4-ylmethyl-6-fluoro-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-5-ylcycloprop.png&w=3840&q=75)
![Chemical structure of (R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F952664-41-4-R-1-22-Difluorobenzod13dioxol-5-yl-N-1-23-dihydroxypropyl-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-5-ylcyclopropane-1-carboxamide.png&w=3840&q=75)
![Chemical structure of (R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-4-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-1-22-Difluorobenzod13dioxol-5-yl-N-1-23-dihydroxypropyl-4-fluoro-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-5-ylcyclopropane-1-carboxamide.png&w=3840&q=75)


![Chemical structure of (R)-N-(1-(3-(Benzyloxy)-2-hydroxypropyl)-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-5-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1294504-68-9-R-N-1-3-Benzyloxy-2-hydroxypropyl-2-1-benzyloxy-2-methylpropan-2-yl-6-fluoro-1H-indol-5-yl-1-22-difluorobenzod13dioxol-5-ylcyclopropane-1.png&w=3840&q=75)



![Chemical structure of 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-((S)-2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indolin-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3007876-86-7-1-22-Difluorobenzod13dioxol-5-yl-N-1-S-23-dihydroxypropyl-6-fluoro-2-1-hydroxy-2-methylpropan-2-ylindolin-5-ylcyclopropane-1-carboxamide.png&w=3840&q=75)
![Chemical structure of 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(6-(2,3-dihydroxypropoxy)-1-(2,3-dihydroxypropyl)-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-22-Difluorobenzod13dioxol-5-yl-N-6-23-dihydroxypropoxy-1-23-dihydroxypropyl-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-5-ylcyclopropane-1-carboxamide.png&w=3840&q=75)
![Chemical structure of 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1152311-65-3-1-22-Difluorobenzod13dioxol-5-yl-N-6-fluoro-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-5-ylcyclopropane-1-carboxamide.png&w=3840&q=75)
![Chemical structure of 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(8-fluoro-2-hydroxy-4-(hydroxymethyl)-1,1-dimethyl-1,2,4,5-tetrahydro-[1,4]oxazepino[4,5-a]indol-9-yl)cyclopropane-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1432657-04-9-1-22-Difluorobenzod13dioxol-5-yl-N-8-fluoro-2-hydroxy-4-hydroxymethyl-11-dimethyl-1245-tetrahydro-14oxazepino45-aindol-9-ylcyclopropane-1.png&w=3840&q=75)

![Chemical structure of 3-(5-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamido)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-1-yl)-2-hydroxypropyl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-5-1-22-Difluorobenzod13dioxol-5-ylcyclopropane-1-carboxamido-6-fluoro-2-1-hydroxy-2-methylpropan-2-yl-1H-indol-1-yl-2-hydroxypropyl-acetate.png&w=3840&q=75)












Tezacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator used in combination therapy to treat cystic fibrosis. This category offers a comprehensive range of Tezacaftor reference standards, including the active pharmaceutical ingredient, potential impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for critical tasks such as impurity profiling, the development of robust analytical methods, and routine quality control. Structurally related analogs and degradation products are essential for assessing drug stability and meeting regulatory requirements for safety and potency. Furthermore, stable isotope-labelled versions are indispensable tools for quantitative bioanalytical assays and precise mass spectrometric identification. By providing access to these specialized compounds, laboratories can ensure accurate characterization of the drug substance and maintain the highest standards in analytical validation and method development.